lek na wirusa C

Gość: Doki Re: lek na wirusa C IP: *.52-136-217.adsl.skynet.be 30.10.03, 20:50

Ze strony: www.boehringer-ingelheim.com/corporate/asp/news/ndetail.asp?ID=1314

28 October 2003

Ingelheim, Germany, 28 October 2003 ? The journal Nature has published an article describing a novel, small molecule anti-hepatitis C virus (HCV) compound discovered by Boehringer Ingelheim at its virology research center in Laval, Québec, Canada. The compound, named BILN 2061, is an orally active inhibitor of the HCV NS3 protease and the first member of this new drug class to be tested in humans. The Nature paper describes the discovery and early clinical trial results with BILN 2061 and demonstrates the promise of this class of anti-HCV agents for the treatment of HCV disease.
Administration of BILN 2061 to a limited number of patients infected with HCV for two days resulted in a marked reduction of the hepatitis C virus plasma levels and established the first proof-of-concept in man for an inhibitor acting by this mechanism. Routine chronic safety testing of high, supra-therapeutic doses in animals did, however, show relevant side effects which need further analysis. Boehringer Ingelheim is currently studying the available pre-clinical data in order to decide on their impact on the clinical development of this substance.

Ja to tlumacze tak: "Ludzie, ale jaja! Dalismy jakies swinstwo paru gosciom z zoltaczka i polepszylo im sie. Wprawdzie na bardzo krotko i nie wiadomo, czy bedzie z tego pozytek, ale fajnie jest, no nie? I laska boska, ze ci goscie nie wykitowali od tego swinstwa. Jak zrobimy tego wiecej, to zobaczymy, czy nie daloby sie sprzedac tego jako lekarstwo. Ludzie wszystko kupia. Ale na razie: cicho, sza!"

A powazniej, nie wiadomo jeszcze czy w ogole cos z tego bedzie.

Drzewko
Od najstarszego
Od najnowszego

Gość: Doki Re: lek na wirusa C IP: *.52-136-217.adsl.skynet.be 30.10.03, 20:50

Ze strony: www.boehringer-ingelheim.com/corporate/asp/news/ndetail.asp?ID=1314

28 October 2003

Ingelheim, Germany, 28 October 2003 ? The journal Nature has published an article describing a novel, small molecule anti-hepatitis C virus (HCV) compound discovered by Boehringer Ingelheim at its virology research center in Laval, Québec, Canada. The compound, named BILN 2061, is an orally active inhibitor of the HCV NS3 protease and the first member of this new drug class to be tested in humans. The Nature paper describes the discovery and early clinical trial results with BILN 2061 and demonstrates the promise of this class of anti-HCV agents for the treatment of HCV disease.
Administration of BILN 2061 to a limited number of patients infected with HCV for two days resulted in a marked reduction of the hepatitis C virus plasma levels and established the first proof-of-concept in man for an inhibitor acting by this mechanism. Routine chronic safety testing of high, supra-therapeutic doses in animals did, however, show relevant side effects which need further analysis. Boehringer Ingelheim is currently studying the available pre-clinical data in order to decide on their impact on the clinical development of this substance.

Ja to tlumacze tak: "Ludzie, ale jaja! Dalismy jakies swinstwo paru gosciom z zoltaczka i polepszylo im sie. Wprawdzie na bardzo krotko i nie wiadomo, czy bedzie z tego pozytek, ale fajnie jest, no nie? I laska boska, ze ci goscie nie wykitowali od tego swinstwa. Jak zrobimy tego wiecej, to zobaczymy, czy nie daloby sie sprzedac tego jako lekarstwo. Ludzie wszystko kupia. Ale na razie: cicho, sza!"

A powazniej, nie wiadomo jeszcze czy w ogole cos z tego bedzie.
- marina2 Re: lek na wirusa C 30.10.03, 21:03
  
  chyba nie ma co czekac na lek, który jest nieskuteczny.Na razie standardowa
  terapia to interferon i rybaviryna .M

Najnowsze z forum Zdrowie

Zaloguj się